Investment Rating - The report suggests a focus on Haisheng Medical as a leading player in the anesthesia and monitoring medical device sector, recommending attention to the company [4][5]. Core Insights - Haisheng Medical is set to issue shares at a price of 12.64 CNY per share with an initial issuance of 11.29 million shares, representing 15% of the total post-issue share capital [4][7]. - The company has a projected total investment of 482.7 million CNY for its fundraising projects, primarily aimed at upgrading and automating its anesthesia monitoring emergency medical devices [4][10]. - The company reported a net profit of 58.78 million CNY for Q1-Q3 2025, reflecting a year-on-year increase of 26.70% [4][12]. - The global low-value consumables market is expected to grow steadily, potentially reaching 129.82 billion USD by 2030, with the Chinese market for low-value medical consumables projected to reach 221.3 billion CNY by 2025 [4][14][18]. Company Overview - Haisheng Medical, established in 2000, specializes in anesthesia and monitoring medical devices, achieving a net profit of 78.04 million CNY in 2023, a year-on-year increase of 11% [4][12]. - The company has developed a comprehensive product matrix covering eight major series, including airway and respiratory management, life information monitoring, and nerve block products [4][14]. - As of November 13, 2025, the company holds 63 national authorized patents, including 13 invention patents, and has 53 medical device registrations [4][14]. Market Potential - The global medical device market is projected to grow from 479.36 billion USD in 2023 to 637.96 billion USD by 2028, with China's medical device market expected to reach 1.66 trillion CNY by 2030 [4][14]. - The demand for low-value medical consumables in China is anticipated to grow rapidly, with the market size expected to reach 221.3 billion CNY in 2025 [4][18]. Subscription Recommendation - Haisheng Medical is positioned as a leading supplier in the anesthesia and monitoring medical device sector, with a strong focus on product quality and continuous technological innovation [4][12].